Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 85%
filed 2026-08-05
EX-99.1
This press release announces the initiation of a Phase IIb clinical trial for SCI-110 at Yale Child Study Center and other sites, representing a material advancement in the company's drug development program for Tourette Syndrome treatment. While the disclosure is operational in nature (a clinical trial milestone), it does not fit the specific `earnings_release` category (no financial results) nor other discrete event types. The Phase IIb launch, building on positive Phase IIa results showing 21% average tic reduction, constitutes a significant clinical and strategic milestone that would affect a reasonable investor's assessment of the registrant's pipeline progress and commercial prospects.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-05
Item 8.01
The disclosure reports commercial progress for LYMPHIR, a recently launched oncology product, including 78% quarter-over-quarter growth in new institutional accounts, expansion to 42 institutions, and near-universal payer coverage. While this is a positive operational update on product commercialization rather than a discrete material event (M&A, impairment, covenant breach, etc.), the metrics indicate material commercial momentum for a key revenue-generating product that would affect investor assessment of the registrant's operational trajectory and market penetration.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-05
Item 8.01
The filing discloses a commercial progress update on LYMPHIR's institutional adoption and market access, including a 78% quarter-over-quarter increase in new institutional accounts ordering the product, expansion to 42 institutions, and near-universal payer coverage. While this is a positive operational/commercial milestone for the company's recently launched oncology product (approved December 2025), it does not fit neatly into the specific event categories (e.g., earnings_release, which typically reports full financial results; operational_other best captures this strategic commercial update). The disclosure is material to investors assessing the company's commercial execution and revenue trajectory for LYMPHIR.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-08-05
EX-99.1
This exhibit discloses a material acquisition-related event: Holcim Ltd.'s request for an extension of the deadline to commence a mandatory Tender Offer (OPA) for Cementos Pacasmayo's remaining shares following Holcim's indirect acquisition of the company's controlling stake through its subsidiary ASPI. The communication references prior material events about the obligation to make the subsequent tender offer and documents Holcim's formal request to the SMV for a 60-business-day extension from the appointment of the valuation entity. This is a material change of control transaction in progress.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-05
EX-99.3
This is a news release dated August 5, 2026 disclosing Greenfire Resources' second quarter 2026 financial and operating results, including bitumen production of 13,607 bbls/d, adjusted funds flow of $21.9 million, and adjusted free cash flow deficit of $34.7 million. The release also announces the closing of the material Connacher Oil and Gas Limited acquisition. While the exhibit contains both an earnings release and M&A activity, the primary disclosure is the Q2 2026 results press release, which is the dominant content and structure of the document.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-05
Item 7.01
This Item 7.01 disclosure furnishes investor presentation materials for an August 5, 2026 webinar. The presentation covers operational and commercial progress including Q2 2026 sales updates ("best quarterly cancer testing revenue to date"), new customer wins (29 new accounts, Maryland firefighter program, Vermont expansion), a new Giant Food pilot for OneTest for Longevity, and CEO's East Asia trip for commercial and M&A exploration. While the filing explicitly disclaims that the furnishing is required by Regulation FD or that materials contain material investor information not otherwise publicly available, the substantive content—revenue milestones, customer acquisitions, product pilots, and strategic expansion—constitutes material operational and commercial developments that would affect a reasonable investor's assessment of the company's business trajectory and growth prospects.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-08-05
Item 7.01
The filing discloses a corporate name change from "Lakeside Holding Limited" to "Quanome Technologies, Inc." and a corresponding ticker symbol change from "LSH" to "QNME" on the Nasdaq Capital Market. While the press release emphasizes strategic repositioning toward quantum technology, the core 8-K disclosure under Item 7.01 is the formal announcement of the name and symbol change—a governance/corporate identity matter. This is material to investors as it reflects a significant rebranding and strategic pivot, though it is primarily administrative in nature rather than a specific named governance event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-05
The 6-K discloses results of Kamada Ltd.'s Annual General Meeting of Shareholders held on August 5, 2026, where shareholders voted on and approved five proposals: re-election of seven directors, re-election of two external directors for a second three-year term, approval of director option grants, amendment to the 2011 Israeli Share Award Plan, and ratification of the independent auditor (Kost Forer Gabbay & Kasierer). This is a classic shareholder_vote_results disclosure reporting the outcomes of an annual meeting vote.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-05
Item 8.01
The disclosure concerns a postponement of a previously announced distribution of BioKey's ordinary shares to ABVC stockholders. Although the distribution has been delayed rather than completed, the event centers on a material capital distribution (spin-off) with a fixed distribution ratio of 0.169464 shares per ABVC share. The postponement itself is material to investors as it affects the timing and mechanics of a significant corporate action, and the filing explicitly addresses the distribution date, ex-dividend date, and record date—hallmarks of a dividend/distribution event.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-05
The filing discloses the appointment of Mr. Kwan Chak Cheung as Chief Financial Officer effective August 5, 2026, to fill the vacancy created by Mr. Kong Wai Wong's resignation. While both a departure and appointment occur, the principal disclosed action is the appointment of a named executive officer to a C-suite role, with detailed background information provided. CFO appointments are material to investors' assessment of financial oversight and governance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-05
EX-99.1
This press release announces execution of a 16-year, $4.7 billion colocation lease and services agreement for Bitdeer's Tydal, Norway AI data center campus with Volta Tydal AS. The transaction represents a material operational and strategic milestone—a major long-term contracted revenue stream (121 IT MW capacity, ~$202/kW/month, 90% NOI margin) with institutional credit support ($1.3B in Letters of Credit from J.P. Morgan and another top-tier institution). While the agreement involves significant contracted revenue and capital deployment (~$500M remaining capex), it is fundamentally an operational/strategic partnership and infrastructure lease arrangement rather than a discrete financial event (debt issuance, M&A, equity dilution) or governance matter. The transaction would materially affect a reasonable investor's assessment of Bitdeer's revenue visibility, capital deployment, and strategic positioning in AI infrastructure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-05
EX-99.1
This press release announces a private placement of 1,000,000 ordinary shares and warrants to purchase 1,000,000 additional shares for approximately $3.3 million gross proceeds. The offering is structured as an unregistered sale under Section 4(a)(2) of the Securities Act, which is a classic dilutive issuance. The company has agreed to file a registration statement for resale, and the warrants are immediately exercisable, both hallmarks of a dilutive capital raise at a small-cap issuer.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-05
The filing discloses a reverse stock split at a 100-for-1 ratio, approved by the Board on July 29, 2026, effective August 10, 2026. This is a material modification to the rights of security holders (Item 3.03) that affects all stockholders uniformly by combining 100 shares into 1 share. While reverse splits are governance-related capital structure events, they do not fit the specific named categories (exec appointment/departure, compensation, M&A, etc.) and are best classified as governance_other. The event is material as it materially affects the registrant's capital structure and would affect a reasonable investor's assessment of share ownership and trading mechanics.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-05
Item 3.02
ISQ Open Infrastructure Co LLC completed unregistered sales of equity securities totaling $16,266,500 across Series I and Series II share classes as of July 1, 2026, exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-05
Item 8.01
ISQ Open Infrastructure Co LLC completed an equity investment acquisition in Subterra Energy Parent, LLC, a natural gas storage platform, in July 2026, representing a material portfolio addition for the infrastructure investment company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
PhenixFIN Corporation issued a press release on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026. The disclosure includes consolidated statements of assets and liabilities, consolidated statements of operations, and key financial metrics (NAV per share of $81.69, net investment income of $2.1 million, total investment income of $6.5 million). This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-08-05
Item 1.01
McKinley Acquisition Corp. entered into a definitive business combination agreement with Space-Eyes, Inc. dated July 30, 2026, providing for a merger resulting in Space-Eyes becoming a wholly-owned subsidiary of McKinley with a $638 million implied equity valuation, $275 million in aggregate consideration, up to $8 million in earn-out shares, and a $75 million PIPE financing. The transaction is expected to close in Q4 2026 and will result in McKinley changing its name to Space-Eyes, Inc. and listing on Nasdaq.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-05
Item 3.02
McKinley Acquisition Corp. disclosed an unregistered private placement (PIPE) of $75 million in senior secured convertible notes, warrants, and underlying shares of common stock representing 9.9% of McKinley's outstanding common stock post-merger, issued under Section 4(a)(2) and Regulation D Rule 506.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
One Liberty Properties issued a press release on August 5, 2026, announcing operating results for the quarter ended June 30, 2026, disclosing net income of $0.71 per diluted share, FFO growth of 8.9%, rental income growth of 10.3% year-over-year, and key balance sheet metrics. This is a standard quarterly earnings release attached as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-05
The Company closed a registered offering of 15,000,000 Class A ordinary shares at $1.00 per share on August 4, 2026, raising approximately $14.562 million in net proceeds. This is a material equity issuance registered under Form F-1, disclosed under the heading "Closing of a Material Transaction" and would materially dilute existing shareholders' ownership and voting power.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
The 8-K discloses quarterly financial results for the three and six months ended June 30, 2026 via a press release dated August 5, 2026. Item 2.02 explicitly states "Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three and six months ended June 30, 2026." The filing includes detailed financial statements showing Q2 2026 net income of $11.4 million ($0.15 per share) and adjusted EBITDA of $23.7 million, representing material improvements from prior-year losses. This is a standard earnings release disclosure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-05
The 8-K discloses under Item 8.01 that the Executive Committee of the Board declared a quarterly cash dividend of $0.0375 per share, payable September 23, 2026 to stockholders of record on September 2, 2026. This is a routine but material dividend distribution to shareholders, supported by the attached press release announcing the dividend declaration.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 95%
filed 2026-08-05
On August 3, 2026, XTL Biopharmaceuticals was served with a shareholder derivative motion in Israeli court alleging that the controlling shareholder and current/former directors breached fiduciary duties in connection with the 2024 acquisition of The Social Proxy Ltd., including alleged failures to fund the subsidiary, conflicts of interest, delayed disclosure, and financial irregularities. The petitioner seeks court authorization to file a derivative claim, monetary compensation estimated at approximately NIS 100 million, disgorgement, forensic accounting, and attorneys' fees. This is a material litigation disclosure involving substantial alleged damages and governance failures.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-05
Item 5.03
FreightCar's Board adopted a limited-duration stockholder rights plan (poison pill) on August 5, 2026, declaring one preferred share purchase right per common share and filing a Certificate of Designation with Delaware. The plan protects against unsolicited takeovers by imposing a 15% (or 20% for 13G investors) ownership threshold and materially affects shareholder voting rights and control dynamics.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-05
Item 2.02
Herbalife disclosed second quarter 2026 financial results via press release, reporting net sales of $1.3 billion (up 5.4% year-over-year), adjusted EBITDA of $166.6 million, and adjusted diluted EPS of $0.51, along with revised full-year 2026 guidance and investor conference call materials.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-05
Item 5.02
Herbalife appointed Scott Schaefer as Chief Financial Officer effective January 1, 2027, succeeding John DeSimone who is retiring December 31, 2026. Schaefer brings 16+ years of experience from Zappos and will receive a compensation package of $650,000 base salary, 80% bonus target, and $1.7 million in long-term incentives.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-05
Item 5.02
The disclosure centers on two compensatory arrangements: (1) Ms. Halisky's new Employment Agreement establishing her annual base salary of $225,000, bonus eligibility, equity participation, and severance terms (replacing her prior independent contractor arrangement), and (2) the Board's establishment of an annual cash compensation program for independent directors at $50,000 per director. Both are material executive and director compensation arrangements that would affect investor assessment of the company's compensation practices and obligations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-05
Item 3.02
The filing discloses unregistered issuance of 1,550,000 shares of common stock in exchange for consulting services under Section 4(a)(2) exemption. This is a classic dilutive equity issuance to service providers, material to investors as it increases share count and dilutes existing shareholders. The Item 3.02 designation and explicit reference to Section 4(a)(2) private placement exemption confirm the dilutive_issuance classification.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-08-05
Item 2.03
The Company entered into two unsecured demand promissory notes totaling $600,000 from NLabs Inc., a principal stockholder and affiliate of the CEO, creating a new direct financial obligation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-05
Item 5.02
Greg Deisher was appointed as Acting Chief Financial Officer, effective July 31, 2026, following the departure of Randal Stephenson. The filing emphasizes Deisher's background and qualifications, with termination agreement details deferred to a future filing.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-05
Item 8.01
The disclosure announces the commencement of separate trading of Class A Ordinary Shares and Warrants that were previously bundled in Units following the Company's IPO. This is an operational/structural event affecting how the Company's securities trade on Nasdaq (symbols "WLCO" and "WLCOW" versus "WLCOU"), but it does not fit neatly into any specific taxonomy category. It is material to investors as it affects the liquidity and trading mechanics of the Company's securities, though it is not a financial obligation, M&A activity, or governance change.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-08-05
EX-99.1
JBS N.V. and its subsidiaries entered into the Sixth Amendment to their Revolving Syndicated Facility Agreement, creating a new senior unsecured revolving credit facility of US$2.65 billion maturing in 2031. The amendment expanded total revolving credit availability by US$650 million from US$3.5 billion to US$4.2 billion, representing a material increase in the company's direct financial obligations and liquidity capacity that would affect investor assessment of capital structure and financial flexibility.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Nine Energy Service issued a press release on August 5, 2026 disclosing second quarter 2026 financial results, including revenues of $141.8 million, net loss of $(4.9) million, and adjusted EBITDA of $8.6 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The press release includes detailed operating results, liquidity position, and forward guidance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-05
The filing discloses results of an extraordinary general meeting held on July 29, 2026, where shareholders voted on multiple proposals including the Business Combination Proposal, Merger Proposal, and Advisory Organizational Documents Proposals. The voting tabulations for each proposal are provided with FOR/AGAINST/ABSTAIN/BROKER NON-VOTES counts, which is the core disclosure required under Item 5.07 (Submission of Matters to a Vote of Security Holders). This is material as it confirms shareholder approval of the proposed business combination with Air Water Ventures.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-08-05
Item 2.03
The Company has established a new direct financial obligation by borrowing approximately $30 million through a DeFi lending facility (Morpho Protocol), secured by Bitcoin collateral at a 4.9% variable interest rate. This is a creation of a direct financial obligation under Item 2.03, fitting the debt_issuance category as it represents a new borrowing arrangement with specified terms, collateral, and interest rates used to fund operations and capital projects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Compass Minerals issued a press release on August 5, 2026, disclosing fiscal 2026 third-quarter financial results, including revenue of $215.3 million, net loss of $5.7 million, and Adjusted EBITDA of $39.9 million. The filing also includes updated full-year 2026 guidance with Adjusted EBITDA raised to a midpoint of $230 million. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-05
Item 5.02
The filing discloses the appointment of Brandon Risner as Chief Operating Officer effective August 3, 2026, following the departure of Patrick Merrin. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new COO with detailed compensation terms (base salary $450,000, 70% bonus target, $600,000 annual equity award target). The appointment of a C-suite executive is material to investors assessing company leadership and operational continuity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
This is a press release announcing Gladstone Commercial Corporation's financial results for the second quarter ended June 30, 2026, filed as Item 2.02 (Results of Operations and Financial Condition). The disclosure includes detailed financial tables showing operating revenue, net income, FFO, Core FFO, and per-share metrics, along with operational highlights and management commentary. This is a standard quarterly earnings release material to investors assessing the REIT's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Kronos Worldwide disclosed second quarter 2026 financial results showing net income of $15.2 million ($0.13 per share) compared to a net loss of $(9.2) million in Q2 2025, along with detailed segment profit and EBITDA metrics.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-05
Item 7.01
Kronos Worldwide's board declared a regular quarterly dividend of $0.05 per share, payable September 17, 2026 to shareholders of record on September 3, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-05
Item 2.02
Universal Technical Institute issued a press release on August 5, 2026, reporting third quarter fiscal 2026 financial results, including revenue of $218.9 million (up 7.2%), net income of $2.3 million, and adjusted EBITDA of $18.2 million, along with updated full-year fiscal 2026 guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
Gran Tierra Energy Inc. issued a press release on August 4, 2026, announcing its financial and operating results for the quarter ended June 30, 2026. The disclosure includes net income of $25 million, adjusted EBITDA of $85 million, production metrics of 41,501 BOEPD, and detailed operational updates across Colombia, Ecuador, and Canada. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-05
Item 2.02
This is a clear earnings release disclosing Primo Brands' financial results for the three and six months ended June 30, 2026. The press release (Exhibit 99.1) presents quarterly net sales of $1,796.2 million (up 3.8%), net income from continuing operations of $69.2 million, Adjusted EBITDA of $385.0 million (up 5.0%), and updated full-year 2026 guidance raising Net Sales growth outlook to 2-4%. The Item 2.02 disclosure explicitly references the full text of the press release furnished as Exhibit 99.1, which is the standard format for earnings announcements.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-05
EX-99.1
This is a news release dated August 5, 2026, announcing Aurora Cannabis's fiscal 2027 first quarter financial results for the period ending June 30, 2026. The exhibit discloses consolidated net revenue of $67.6 million, gross profit, operating expenses, net loss from continuing operations of $4.0 million, adjusted EBITDA of $3.4 million, and free cash flow metrics, along with segment performance (medical cannabis, consumer cannabis, wholesale bulk cannabis). The release includes management commentary on operational performance and forward-looking guidance. This is a classic earnings release disclosing quarterly financial results.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-05
EX-99.1
The exhibit announces the appointment of Luis Lázaro as President, Mexico, effective immediately, a new executive role reporting to the CEO. While the release also discloses the resignation of Jesus Velador as Chief Geologist (effective August 27, 2026), the principal disclosed action is Lázaro's appointment to a material operational leadership position overseeing in-country operations and the flagship Panuco project during a critical transition to construction and production. This is a material executive appointment that would affect investor assessment of management depth and operational capability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-05
Item 2.02
LegalZoom issued a press release on August 5, 2026 announcing second quarter 2026 financial results, including revenue of $205.3 million (up 7% year-over-year), net income of $5.2 million, and Adjusted EBITDA of $45.9 million, along with updated full-year 2026 guidance (revenue $795–$805 million, Adjusted EBITDA $190–$195 million) and Q3 2026 guidance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-05
This is a quarterly earnings release for Q2 2026 (ended June 30, 2026) disclosing consolidated financial and operating results for CCU (Compañía Cervecerías Unidas S.A.). The document presents key financial metrics including volumes, net sales (CLP 607,801 million, up 4.8%), gross profit, EBITDA (CLP 31,591 million, up 59.4%), and net income (loss of CLP 20,712 million), along with segment-level performance and CEO commentary. This is a material event affecting investor assessment of the registrant's financial performance and operational status.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-05
EX-99.1
This is an announcement of the timing and date for release of second quarter 2026 earnings results (August 14, 2026), coupled with preliminary production metrics. The exhibit discloses that Sigma Lithium exceeded its 2Q26 production guidance by 6% (delivering 35,000 tonnes) and achieved 58,000 tonnes for the first half of 2026, above target. While not the full earnings release itself, this is a material pre-announcement of financial results and operational performance that would affect investor assessment of the company's execution and guidance accuracy.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-05
EX-99.1
This is a quarterly earnings release for Nexa Resources announcing Q2 2026 financial results. The document explicitly states "Nexa Reports Second Quarter 2026 Results including Net Income of US$98 million and Adjusted EBITDA of US$286 million" and includes comprehensive financial tables showing net revenues (US$908M), net income, EBITDA, EPS, and operational metrics for the quarter and half-year periods. The release is dated August 5, 2026, and is furnished as an exhibit to the 6-K filing.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-05
EX-99.1
Ecopetrol announces successful completion of a voluntary tender offer (OPAV) to acquire approximately 25% of Brava Energia S.A.'s share capital (116,110,717 shares at R$23.00 per share) on August 5, 2026. This is a material acquisition milestone that is part of a larger transaction announced April 23, 2026, whereby Ecopetrol Brasil is expected to acquire controlling interest of approximately 51% of Brava's voting share capital. The completion of the auction process and pending settlement on August 17, 2026, represents a significant step in a material M&A transaction.
View raw filing on EDGAR →